The rising incidence of various chronic conditions and diseases such as Parkinson’s disease, diabetes, and Alzheimer’s disease is pushing up the demand for stem cells and cord blood cells across the globe, on account of the fact that these therapies can help considerably in organ transplantation, tissue grafting, drug testing, and the development of regenerative medicine. This is subsequently pushing up the requirement for biobanks and biobanking solutions across the world.
Moreover, due to the surging demand for finding proper and effective treatment procedures for various chronic diseases such as ischemic heart diseases, respiratory disorders, cancer, and diabetes, the governments and national bodies/institutes of many countries are making huge investments in biobanks for preserving, analyzing, transporting, and collecting blood samples. For example, the German Federal Ministry of Education and Research (BMBF) made an allocation of $16 million to 11 German biobanks in May 2017.
Due to the aforementioned factors, the demand for biobanks is growing rapidly across the world. This is driving the advancement of the global biobanking market. As a result, the valuation of the market is predicted to surge from $25.8 billion in 2018 to $36.8 billion by 2024. Furthermore, the market is predicted to progress at a CAGR of 6.2% between 2019 and 2024. Depending on offering, the market is divided into services, software, equipment, and consumables.
Browse detailed report on Global Biobanking Market Growth and Future Analysis
Out of these, the consumables category is predicted to demonstrate the highest growth in the market in the future years. Furthermore, the software category is predicted to exhibit rapid expansion in the biobanking market in the forthcoming years. When the type of sample is taken into consideration, the market is classified into human tissues, blood products and genetic materials, biological fluids, human waste products, cell lines, and human tissues categories.
Out of these, the blood products and genetic material category will register the highest growth in the market in the upcoming years, as per the estimates of P&S Intelligence, a market research company based in India. This is credited to the growing requirement for the preservation of various blood products such as serum, plasma, and platelets all over the world on account of the growing incidence of chronic diseases across the world.
Globally, the biobanking market is predicted to demonstrate lucrative growth in the Asia-Pacific (APAC) region in the coming years. This will be a result of the surging clinical research activities and the soaring population of geriatric people in the regional countries. Apart from these factors, the rapid expansion of the biotechnology sector, because of the huge investments being made in this sector by both private and public organizations, is also propelling the demand for biobanks in the APAC region.
Hence, it can be said with full confidence that the demand for biobanks will surge all over the world in the coming years, primarily because of the rising incidence of chronic diseases, the soaring geriatric population, and the allocation of huge funds for the development of biobanks in healthcare facilities around the world.
Global Cell Lines Market - A Report by Fact.MRAccording to Fact.MR, the global cell lines market is anticipated to show a value of more than US$ 140 Mn and expected to grow at a steady rate during the period of forecast.
Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global cell lines market.
The cell lines market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth.
Each segment alongwith its sub-segment is analyzed in terms of value and volume.
Further, the cell lines market report elaborates the market behavior of each vendor operating in the cell lines market.Cell lines are used in research and biologics and used in drug discovery, molecular biology, biochemistry, cell biology etc.
The global cell lines market is influenced by several advantages that the cell liens offer, which include ease in use, cost effectiveness, as well as they provide pure cells which are needed to obtain reproducible results along with consistent samples.The cell lines market report considers the following years to present the overall market growth:History Year: 2012-2016Base Year: 2012Estimated Year: 2022Forecast Year: 2017 – 2022Key findings of the cell lines market study:Regional breakdown of the cell lines market based on predefined taxonomy.Innovative manufacturing processes implemented by cell lines market vendors in detail.Region-wise and country-wise fragmentation of the cell lines market to grasp the revenue, and growth outlook in these areas.Changing preferences among consumers across various regions and countries.Factors (Positive and Negative) impacting the growth of the global cell lines market.Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=180Moreover, the growing technological developments in the healthcare industry, new innovations and increased investment in the research and development has resulted in the discovering several paradigms for cell lines, thereby pushing the growth of the global cell lines market.
FactMR, a leading authority on market research brings original, in-depth, and insightful reports to investors.
The company is a leading voice in the world of market research, which has become a breeding ground for informed decision-making, and quick decision-making abilities.
FactMR’s new report will highlight various growth forecasts, key trends, and notable segments ripe for upcoming investments.
The business report highlights the drivers, restraints, opportunities and trends affecting cell lines market growth.
Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.FactMR promises to ready new investors in the world of digital age with information from key stakeholders in the industry, objective forecasts, and independent analysis of a wide range of viewpoints.
The company leverages information from key stakeholders of information including World Bank, the UNO, WHO, among others to tackle challenges of investing head-on.For the cell lines market, FactMR has considered 2018 as the base year for projections, while 2019-2029 period as the forecast period.
The Cryopreservation Cell Lines Market 2021 research report gives emerging industry data, global segments and regional outlook.
This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the cryopreservation cell lines market include Thermo Fisher Scientific, Inc., ATCC, Corning Incorporated, ABM Inc, Zenbio, REPROCELL USA Inc. and many more.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Cryopreservation Cell Lines Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/cryopreservation-cell-lines-market/download-sampleMarket DynamicsThey prevent vascular damage affected during the expansion of blood vessels and find applications in reparative and regenerative medicine and cell-based therapy.
When it is a wave of digitization in every aspect then why leave the healthcare and life sciences industry behind with digital health technology being the top priority.
However, there are few of the crucial points to cover through digitization in life sciences.Making lives easier and better is the sole purpose of the digital era and utilizing that era to enhance the processes by producing better outcomes in less time is the aim and demand.It is more of a technology disruption that will move over the healthcare and life sciences industry.
Technology is making the aspect of life sciences simple with effacing the previous ways of testing and providing medication and treatment with better solutions.
By adopting digitization the life sciences companies can obtain a great number of patient outcomes that too in a careful and cost-effective manner.
As per the healthcare market research the whole of the market is customer-centric and the era digitization, there is a demand for quality of services and to have control over the services and solutions being provided to the customers.Technology has made the delivery of better customer experience and relationship with digitization in the healthcare and life sciences industry and it is experiencing great turn-of-events.
The data, medication, and details are all online and customers can easily access them as they are personalized.As per statistics, the health information search is the third common search request found on the internet and 77% of the patients are accessing online sources before appointing a treatment with a doctor.
Digital transformation are available throughout a life sciences organization, from improving finance, supply chain, and manufacturing operations, to developing new products and services, to engaging differently with customers and patients.
Softcon Systems deliver integrated solutions and service offerings to enable these automation solutions including Data history & integrity, Data analytics, Batch processing, Plant-wide automation and manufacturing compliance.
